JohnRobertSchreiberMDMPH

Pediatric Infectious Disease • Hartford, CT

Medical Microbiology, Pediatric Vaccinology and Vaccine Preventable Diseases

Retired, CEO, Medical College Physicians; Senior Associate Dean for Clinical Affairs, Professor of Pediatrics and Microbiology/Immunology at Medical College of Wisconsin

Join to view full profile

Dr. Schreiber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schreiber's full profile

Already have an account?

Office
282 Washington St
Hartford, CT 06106
Phone+1 860-545-9000

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 1982 - 1985
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1980 - 1982
Tulane University School of MedicineClass of 1980

Certifications & Licensure

NY State Medical License 1987 - Present
CT State Medical License 2019 - 2025
MD State Medical License 2011 - 2021
DC State Medical License 2006 - 2020
VA State Medical License 2013 - 2020
FL State Medical License 2017 - 2019
WI State Medical License 2017 - 2019
MA State Medical License 1982 - 2017
MN State Medical License 2004 - 2007
OH State Medical License 1988 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases
Join now to see all

Awards, Honors, & Recognition

Distinguished Service Award American Association of Immunologists, 2012

Publications & Presentations

PubMed

19 citations
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
Joelynn Dailey, Lina Kozhaya, Mikail Dogan, Dena Hopkins, Blaine Lapin
Inflammatory Bowel Diseases. 2021-09-16
22 citations
Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time.
Michael Neely, John R. Schreiber
Pediatrics. 2001-02-01
41 citations
Immunization with Haemophilus influenzae Type b-CRM197 Conjugate Vaccine Elicits a Mixed Th1 and Th2 CD4+ T Cell Cytokine Response That Correlates with the Isotype of ...
Kulwant K. Kamboj, Christopher L. King, Neil S. Greenspan, H. Lester Kirchner, John R. Schreiber
The Journal of Infectious Diseases. 2001-10-01

Press Mentions

COVID Vaccines Now Authorized for Children from 6 Months and OlderJune 24th, 2022
Vaccination Rates Among CT Schoolchildren Drop Amid COVID-19June 19th, 2022
Connecticut Prepares to Roll Out COVID Vaccines for Young ChildrenJune 17th, 2022
Join now to see all

Grant Support

Antigen Processing of Pneumococcal conjugate vaccineNational Institutes of Allergy, Immunology, Infectious Diseases (NIAID)2011–Present
U Of MN Child Health Research Career Development AwardEunice Kennedy Shriver National Institute Of Child Health &Human Development2005
IGG Subclass And Function Of Anti-Polysaccharide AbsNational Institute Of Allergy And Infectious Diseases2004–2005
Human T Cell Response To Pneumococcal Conjugate VaccinesNational Institute Of Allergy And Infectious Diseases2004
Training Program In Pediatric Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2002–2003
IGG Subclass And Function Of Anti-Polysaccharide AbsNational Institute Of Allergy And Infectious Diseases2002–2003
Teaching Biology Through Immunology FellowshipsNational Institute Of Allergy And Infectious Diseases2001–2003
Human T Cell Response To Pneumococcal Conjugate VaccinesNational Institute Of Allergy And Infectious Diseases2000–2003
IGG Class And Function Of Antipolysaccharide AntibodiesNational Institute Of Allergy And Infectious Diseases1998–2001
Antiidiotype Induced Immunity To Pseudomonas AeruginosaNational Institute Of Allergy And Infectious Diseases1996–1999
Gene Therapeutic Approach For Tolerance InductionNational Institute Of Allergy And Infectious Diseases1997
Core--Monoclonal AntibodyNational Heart, Lung, And Blood Institute1997
Regulation Of B Lymphoma Growth And ApoptosisNational Cancer Institute1996–1997
Regulation Of B Cell Responsiveness To GP120National Institute Of Allergy And Infectious Diseases1995–1997
Enhancing Science Education Through ImmunologyNational Institute Of Allergy And Infectious Diseases1996
IGG Subclass &Function Of Antipolysaccharide AntibodyNational Institute Of Allergy And Infectious Diseases1994–1996
Regulation Of Murine B Lymphoma Growth By Antiig/Tgf-BNational Cancer Institute1994–1995
Regulation Of Specific B-Cell ResponsesNational Institute Of Allergy And Infectious Diseases1994
Regulation Of Specific B Cell ResponsesNational Institute Of Allergy And Infectious Diseases1994
IGG Subclass &Function Of Anti-Polysaccharide AntibodyNational Institute Of Allergy And Infectious Diseases1993
Regulation Of Murine B Lymphoma Growth By Anti-Ig/Tgf-BNational Cancer Institute1993
Regulation Of Specific B Cell ResponsesNational Institute Of Allergy And Infectious Diseases1990–1993
Regulation Of Murine B Lymphoma Growth By Anti-Ig TfbgNational Cancer Institute1992
Anti-Idiotype Induced Immunity Against P. AeruginosaNational Institute Of Allergy And Infectious Diseases1988–1992
Mechanism Of Specific B Lymphoctte ToleranceNational Cancer Institute1986–1988
Immune Response To Modified Self And Tumor AntigensNational Cancer Institute1985